Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 214,415 | 236,809 | 235,048 | 232,186 | 217,914 |
| Marketable Securities | 59,669 | 28,693 | 28,693 | 35,693 | 35,694 |
| Receivables | 267,188 | 264,413 | 278,849 | 262,160 | 284,507 |
| Inventories | 492,005 | 495,035 | 492,735 | 489,106 | 465,127 |
| Other current assets | 53,861 | 49,354 | 28,130 | 30,326 | 36,121 |
| TOTAL | $1,191,482 | $1,172,017 | $1,159,544 | $1,143,582 | $1,142,828 |
| Non-Current Assets | |||||
| PPE Net | 446,202 | 446,882 | 444,335 | 437,367 | 434,816 |
| Intangibles | 1,686,687 | 1,718,592 | 1,749,820 | 1,775,344 | 1,804,507 |
| Other Non-Current Assets | 239,119 | 240,235 | 248,302 | 290,159 | 285,754 |
| TOTAL | $2,372,008 | $2,405,709 | $2,442,457 | $2,502,870 | $2,525,077 |
| Total Assets | $3,563,490 | $3,577,726 | $3,602,001 | $3,646,452 | $3,667,905 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 87,800 | 0 | 574,628 |
| Accounts payable and accrued liabilities | 82,637 | 87,948 | 95,726 | 92,305 | 92,835 |
| Accrued Expenses | 175,795 | 191,357 | 204,572 | 207,847 | 198,314 |
| Other current liabilities | 11,699 | 11,623 | 11,463 | 11,326 | 11,103 |
| TOTAL | $330,881 | $346,846 | $455,981 | $364,054 | $929,806 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,828,705 | 1,826,655 | 1,729,556 | 1,792,351 | 1,226,942 |
| Other Non-Current Liabilities | 357,057 | 355,676 | 367,337 | 394,188 | 412,432 |
| TOTAL | $2,189,232 | $2,188,474 | $2,102,557 | $2,244,824 | $1,699,438 |
| Total Liabilities | $2,520,113 | $2,535,320 | $2,558,538 | $2,608,878 | $2,629,244 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 77,773 | 77,797 | 77,937 | 77,892 | 77,911 |
| Common Shares | 921 | 922 | 923 | 923 | 923 |
| Retained earnings | 423,306 | 418,824 | 423,441 | 425,145 | 430,549 |
| Other shareholders' equity | -40,115 | -31,062 | -30,287 | -32,000 | -30,941 |
| TOTAL | $1,043,377 | $1,042,406 | $1,043,463 | $1,037,574 | $1,038,661 |
| Total Liabilities And Equity | $3,563,490 | $3,577,726 | $3,602,001 | $3,646,452 | $3,667,905 |